Landscapes / Targets

JAK1

9 drugs act on JAK1, in 53 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs9

DrugHow it worksCompanyStageNext dateDetails
Janus kinase inhibitor
Approved in the EU 20 Nov 2026soonPhase 2 trial completes
Janus kinase inhibitor
AbbVie · Public ABBV
Approved Nov 2026soonPhase 3 trial completes
Tyrosine kinase inhibitor
Approved 11 Dec 2026soonPhase 2 trial completes
Janus kinase inhibitor
Approved in China Dec 2026Phase 1/2 trial completes
Janus kinase inhibitor
Pfizer · Public PFE
Approved 2 May 2027Phase 3 trial completes
JAK inhibitor
Approved in the EU Jun 2027Phase 3 trial completes
JAK inhibitor
Approved in Japan 30 Nov 2027Phase 4 trial completes
Janus kinase inhibitor
Priovant Therapeutics +1 · Public PFE
Approved 31 Dec 2028Phase 2/3 trial completes
Tyrosine kinase inhibitor
Phase 1/2 Nov 2026soonPhase 1/2 trial completes

About this list

Checked
9 of 9 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow JAK1

Following is part of Solo: you see every change to JAK1 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in